Preconceived notions about biosimilars-a French experience.
Clin Rheumatol
; 39(8): 2251-2254, 2020 Aug.
Article
em En
| MEDLINE
| ID: mdl-32572806
ABSTRACT
Since the arrival of the first biosimilar monoclonal antibodies into the market, many information has been circulating, leading to preconceived notions for patients and healthcare professionals. In a pressing economic context and faced with a growing number of available biosimilars, we (clinician, patient association, biologist, pharmacists, health economists) propose to take stock by trying to distinguish facts from misconceptions.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Produtos Biológicos
/
Atitude do Pessoal de Saúde
/
Medicamentos Biossimilares
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
En
Revista:
Clin Rheumatol
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
França